These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1354726)

  • 21. Stability of a transdermal salmon calcitonin formulation.
    Chang SL; Hofmann GA; Zhang L; Deftos LJ; Banga AK
    Drug Deliv; 2003; 10(1):41-5. PubMed ID: 12554363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of salmon calcitonin (sCT) enteric-coated capsule for enhanced absorption and GI tolerability in rats.
    Wu L; Zhang G; Lu Q; Sun Q; Wang M; Li N; Gao Z; Sun Y; Li T; Han D; Yu X; Wang L; Sun W; Zhao D; Wu Y; Lu Y; Chen X
    Drug Dev Ind Pharm; 2010 Mar; 36(3):362-70. PubMed ID: 19719396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of dermal blood supply and epidermis on the transdermal iontophoretic delivery of monovalent cations.
    Cross SE; Roberts MS
    J Pharm Sci; 1995 May; 84(5):584-92. PubMed ID: 7658349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal delivery of PEGylated salmon calcitonins: hypocalcemic effects in rats.
    Lee KC; Park MO; Na DH; Youn YS; Lee SD; Yoo SD; Lee HS; DeLuca PP
    Calcif Tissue Int; 2003 Dec; 73(6):545-9. PubMed ID: 14508623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypocalcemic effect of salmon calcitonin following single and repeated nasal and intravenous administration in young rabbits.
    Schipper NG; Romeijn SG; Verhoef J; Merkus FW
    Calcif Tissue Int; 1994 Jan; 54(1):50-5. PubMed ID: 8118754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracerebroventricular injection of 125I-salmon calcitonin in rats: fate, anorexia and hypocalcemia.
    Morimoto T; Okamoto M; Koida M; Nakamuta H; Stahl GL; Orlowski RC
    Jpn J Pharmacol; 1985 Jan; 37(1):21-9. PubMed ID: 3990041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous absorption of physiologically active peptides, ebiratide and elcatonin, in rats.
    Ogiso T; Paku T; Iwaki M; Tanino T; Nishioka S
    Biol Pharm Bull; 1994 Aug; 17(8):1094-100. PubMed ID: 7820115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of bioavailability of salmon calcitonin from the hypocalcemic effect in rats (II): effect of protease inhibitor on the pharmacokinetic-pharmacodynamic relationship after intranasal administration.
    Miyazaki M; Nakade S; Iwanaga K; Morimoto K; Kakemi M
    Drug Metab Pharmacokinet; 2003; 18(6):358-64. PubMed ID: 15618756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superior local tolerability of human versus salmon calcitonin preparations in young healthy volunteers.
    Wüster C; Schurr W; Scharla S; Raue F; Minne HW; Ziegler R
    Eur J Clin Pharmacol; 1991; 41(3):211-5. PubMed ID: 1748138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary delivery of salmon calcitonin dry powders containing absorption enhancers in rats.
    Kobayashi S; Kondo S; Juni K
    Pharm Res; 1996 Jan; 13(1):80-3. PubMed ID: 8668684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of hypocalcemia by intracerebroventricular injection of calcitonin: evidence for control of blood calcium by the nervous system.
    Goltzman D; Tannenbaum GS
    Brain Res; 1987 Jul; 416(1):1-6. PubMed ID: 3620946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategic approaches for enhancement of in vivo transbuccal peptide drug delivery in rabbits using iontophoresis and chemical enhancers.
    Oh DH; Kim MJ; Jeon SO; Seo JE; Jeong SH; Kang JW; Choi YW; Lee S
    Pharm Res; 2015 Mar; 32(3):929-40. PubMed ID: 25231009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats.
    Yamamoto A; Taniguchi T; Rikyuu K; Tsuji T; Fujita T; Murakami M; Muranishi S
    Pharm Res; 1994 Oct; 11(10):1496-500. PubMed ID: 7855059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of drug delivery systems for a therapeutic agent used in osteoporosis. II. Enhanced absorption of elcatonin from nasal mucosa in rabbits.
    Watanabe Y; Mizufune Y; Utoguchi N; Endo K; Matsumoto M
    Biol Pharm Bull; 1998 Nov; 21(11):1191-4. PubMed ID: 9853411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gelatin microspheres as a pulmonary delivery system: evaluation of salmon calcitonin absorption.
    Morimoto K; Katsumata H; Yabuta T; Iwanaga K; Kakemi M; Tabata Y; Ikada Y
    J Pharm Pharmacol; 2000 Jun; 52(6):611-7. PubMed ID: 10875536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents: implications in peptide delivery to the colon.
    Tozaki H; Emi Y; Horisaka E; Fujita T; Yamamoto A; Muranishi S
    J Pharm Pharmacol; 1997 Feb; 49(2):164-8. PubMed ID: 9055189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.
    Liu L; Yang H; Lou Y; Wu JY; Miao J; Lu XY; Gao JQ
    Int J Pharm; 2019 Feb; 557():170-177. PubMed ID: 30597264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and characterization of salmon calcitonin-sodium triphosphate ionic complex for oral delivery.
    Lee HE; Lee MJ; Park CR; Kim AY; Chun KH; Hwang HJ; Oh DH; Jeon SO; Kang JS; Jung TS; Choi GJ; Lee S
    J Control Release; 2010 Apr; 143(2):251-7. PubMed ID: 20026364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of salmon calcitonin particles for nasal delivery using spray-drying and novel supercritical fluid-assisted spray-drying processes.
    Cho W; Kim MS; Jung MS; Park J; Cha KH; Kim JS; Park HJ; Alhalaweh A; Velaga SP; Hwang SJ
    Int J Pharm; 2015 Jan; 478(1):288-296. PubMed ID: 25445994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of regional intestinal pH modulation on absorption of peptide drugs: oral absorption studies of salmon calcitonin in beagle dogs.
    Lee YH; Perry BA; Labruno S; Lee HS; Stern W; Falzone LM; Sinko PJ
    Pharm Res; 1999 Aug; 16(8):1233-9. PubMed ID: 10468025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.